Sei già registrato?

Accedi alla tua sezione

Non ricordi la password?

Contatti info@siaaic-channel.it

Sei già registrato?

Accedi alla tua sezione

Non ricordi la password?

Contatti info@siaaic-channel.it

Segreteria Organizzativa

All rights reserved. Privacy policy Legal Notices Cookie policy

FAVORABLE BENEFIT-RISK PROFILE OF AVAPRITINIB IN INDOLENT SYSTEMIC MASTOCYTOSIS IS MAINTAINED AFTER 3 YEARS OF THERAPY: LONGER-TERM ANALYSIS OF THE PIONEER STUDY

Triggiani Massimo

Poster
FAVORABLE BENEFIT-RISK PROFILE OF AVAPRITINIB IN INDOLENT SYSTEMIC MASTOCYTOSIS IS MAINTAINED AFTER 3 YEARS OF THERAPY: LONGER-TERM ANALYSIS OF THE PIONEER STUDY

Segreteria Organizzativa

All rights reserved. Privacy policy Legal Notices Cookie policy